These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 38791159

  • 1. Characterizing Glomerular Barrier Dysfunction with Patient-Derived Serum in Glomerulus-on-a-Chip Models: Unveiling New Insights into Glomerulonephritis.
    Kim SY, Choi YY, Kwon EJ, Seo S, Kim WY, Park SH, Park S, Chin HJ, Na KY, Kim S.
    Int J Mol Sci; 2024 May 08; 25(10):. PubMed ID: 38791159
    [Abstract] [Full Text] [Related]

  • 2. Expression of nephrin in acquired human glomerular disease.
    Huh W, Kim DJ, Kim MK, Kim YG, Oh HY, Ruotsalainen V, Tryggvason K.
    Nephrol Dial Transplant; 2002 Mar 08; 17(3):478-84. PubMed ID: 11865096
    [Abstract] [Full Text] [Related]

  • 3. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.
    Pol J Pathol; 2006 Mar 08; 57(1):17-21. PubMed ID: 16739878
    [Abstract] [Full Text] [Related]

  • 4. Glomerular Endothelial Cell-Derived microRNA-192 Regulates Nephronectin Expression in Idiopathic Membranous Glomerulonephritis.
    Müller-Deile J, Sopel N, Ohs A, Rose V, Gröner M, Wrede C, Hegermann J, Daniel C, Amann K, Zahner G, Schiffer M.
    J Am Soc Nephrol; 2021 Nov 08; 32(11):2777-2794. PubMed ID: 34716242
    [Abstract] [Full Text] [Related]

  • 5. Co-Culture of Glomerular Endothelial Cells and Podocytes in a Custom-Designed Glomerulus-on-a-Chip Model Improves the Filtration Barrier Integrity and Affects the Glomerular Cell Phenotype.
    't Hart DC, Yildiz D, Palacio-Castañeda V, Li L, Gumuscu B, Brock R, Verdurmen WPR, van der Vlag J, Nijenhuis T.
    Biosensors (Basel); 2023 Mar 03; 13(3):. PubMed ID: 36979551
    [Abstract] [Full Text] [Related]

  • 6. No complement receptor 1 stumps on podocytes in human glomerulopathies.
    Moll S, Miot S, Sadallah S, Gudat F, Mihatsch MJ, Schifferli JA.
    Kidney Int; 2001 Jan 03; 59(1):160-8. PubMed ID: 11135068
    [Abstract] [Full Text] [Related]

  • 7. [Expression of neonatal Fc receptor on human nephritis and rat nephritis models].
    Feng ST, Gan HL, Sun JY, Jiang T, Liu BL, Zhao ZH, Guo MY, Zhang ZG.
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb 03; 41(2):81-5. PubMed ID: 22455882
    [Abstract] [Full Text] [Related]

  • 8. Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986-2015.
    O'Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, Jennette JC.
    Clin J Am Soc Nephrol; 2017 Apr 03; 12(4):614-623. PubMed ID: 28325866
    [Abstract] [Full Text] [Related]

  • 9. Development of Drug Efficacy Testing Platform for Glomerulonephritis.
    Kwon EJ, Choi Y, Kim SY, Park S, Yun G, Min SH, Kim S.
    Micromachines (Basel); 2024 Feb 24; 15(3):. PubMed ID: 38542564
    [Abstract] [Full Text] [Related]

  • 10. Generation of a Glomerular Filtration Barrier on a Glomerulus-on-a-Chip Platform.
    Perin L, Da Sacco S.
    Methods Mol Biol; 2022 Feb 24; 2373():121-131. PubMed ID: 34520010
    [Abstract] [Full Text] [Related]

  • 11. A disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice.
    Wang L, Tao T, Su W, Yu H, Yu Y, Qin J.
    Lab Chip; 2017 May 16; 17(10):1749-1760. PubMed ID: 28418422
    [Abstract] [Full Text] [Related]

  • 12. Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China.
    Chen L, Luodelete M, Dong C, Li B, Zhang W, Nie P, Liu J, Chen X, Luo P.
    Ren Fail; 2019 Nov 16; 41(1):473-480. PubMed ID: 31198075
    [Abstract] [Full Text] [Related]

  • 13. The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis.
    Niemir ZI, Stein H, Ciechanowicz A, Olejniczak P, Dworacki G, Ritz E, Waldherr R, Czekalski S.
    Am J Kidney Dis; 2004 Jun 16; 43(6):983-98. PubMed ID: 15168378
    [Abstract] [Full Text] [Related]

  • 14. [Histological classification of chronic glomerular diseases].
    Noël LH, Gubler MC.
    Rev Prat; 2003 Nov 30; 53(18):2005-12. PubMed ID: 15008214
    [Abstract] [Full Text] [Related]

  • 15. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
    Mizdrak M, Vukojević K, Filipović N, Čapkun V, Benzon B, Durdov MG.
    Diagn Pathol; 2018 Nov 20; 13(1):90. PubMed ID: 30458823
    [Abstract] [Full Text] [Related]

  • 16. The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study.
    Yuan M, Tan Y, Wang Y, Wang SX, Yu F, Zhao MH.
    Lupus; 2019 Mar 20; 28(3):347-358. PubMed ID: 30755145
    [Abstract] [Full Text] [Related]

  • 17. Characterization and quantification of proliferating cell patterns in endocapillary proliferation.
    Wu Q, Tanaka H, Hirukawa T, Endoh M, Fukagawa M.
    Nephrol Dial Transplant; 2012 Aug 20; 27(8):3234-41. PubMed ID: 22431704
    [Abstract] [Full Text] [Related]

  • 18. A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier.
    Petrosyan A, Cravedi P, Villani V, Angeletti A, Manrique J, Renieri A, De Filippo RE, Perin L, Da Sacco S.
    Nat Commun; 2019 Aug 13; 10(1):3656. PubMed ID: 31409793
    [Abstract] [Full Text] [Related]

  • 19. Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis.
    Xu C, Miao Y, Pi Q, Zhu S, Li F.
    Clin Immunol; 2018 Dec 13; 197():179-185. PubMed ID: 30296590
    [Abstract] [Full Text] [Related]

  • 20. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
    Nawata A, Hisano S, Shimajiri S, Wang KY, Tanaka Y, Nakayama T.
    Histopathology; 2018 Jun 13; 72(7):1084-1092. PubMed ID: 29247494
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.